Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05076578 · ClinicalTrials.gov registry record · NA
A Prospective Clinical Study Evaluating the Harvesting of Micografts
A NA study, sponsored by SerenaGroup.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05076578 is a NA study that has completed, run by SerenaGroup. The registered enrollment target is 20 participants.
The verdict
NCT05076578, a NA study, has completed, sponsored by SerenaGroup.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
ART (Autologous Regeneration of Tissue) is a revolutionary technology for harvesting skin without the drawbacks of conventional grafting. This innovative system allows the clinician to collect hundreds of microcolumns of full-thickness skin tissue and apply them directly to the wound site. It can all be done in an outpatient setting with minimized donor site concerns.
Interventions
- DEVICE Autologous Regeneration of Tissue (ARTTM) system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-13 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05076578
The ClinicalTrials.gov registry entry for NCT05076578 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SerenaGroup, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autologous Regeneration of Tissue (ARTTM) system is the first listed.
NCT05076578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05076578 about?
NCT05076578 is a clinical study titled "A Prospective Clinical Study Evaluating the Harvesting of Micografts". ART (Autologous Regeneration of Tissue) is a revolutionary technology for harvesting skin without the drawbacks of conventional grafting. This innovative system allows the clinician to collect hundreds of microcolumns of full-thickness skin tissue and apply them directly to the wound site. It can al...
What is the current status of trial NCT05076578?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-09-13. Estimated completion is 2022-02-01.
What interventions are being tested in trial NCT05076578?
The interventions under investigation include: Autologous Regeneration of Tissue (ARTTM) system (DEVICE).
Who is sponsoring clinical trial NCT05076578?
This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.